China’s National Medical Products Administration Releases Implementation Measures for Drug Trial Data Protection – May 30, 2026 Submission Deadline!
On May 15, 2026, China’s National Medical Products Administration (NMPA) released the Implementation Measures for Drug Trial Data Protection (药品试验数据保护实施办法), effective May 15, 2026. The Measures provide equal drug trial data protection terms for domestic and foreign-developed drugs. The data protection scope includes all test data used in the drug marketing authorization application to demonstrate […]